Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2019

Apr 24, 2019

SELL
$20.23 - $26.29 $20,230 - $26,290
-1,000 Reduced 83.33%
200 $3,000
Q4 2018

Feb 01, 2019

BUY
$17.64 - $28.32 $3,528 - $5,664
200 Added 20.0%
1,200 $2,000
Q3 2018

Oct 25, 2018

BUY
$20.64 - $25.67 $20,640 - $25,670
1,000 New
1,000 $0

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.33B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.